Literature DB >> 208436

Influence of thymectomy on the susceptibility of cats to feline leukemia virus and lymphosarcoma.

E A Hoover, S Krakowka, G L Cockerell, L E Mathes, R G Olsen.   

Abstract

Twelve cats were thymectomized at 5 weeks of age. Six of these cats were inoculated at 8 weeks of age and 6 at 4 months of age with the Rickard (R) strain of feline leukemia virus (FeLV), which produces a high incidence of thymic lymphosarcoma. Two groups of age-matched nonthymectomized cats were inoculated with the same FeLV-R stock. Thymectomy prior to FeLV infection had no influence on the induction of viremia or the incidence of lymphosarcoma. In the FeLV-inoculated nonthymectomized cats, lymphosarcoma developed in the thymus. In the thymectomized cats, lymphosarcoma developed in the intestine, mesenteric lymph nodes, and bone marrow, but the malignant lymphoblasts had surface markers characteristic of feline T lymphocytes. It was concluded that the presence of the thymus per se is not required for infection and oncogenesis by FeLV and that feline T lymphocytes may be transformed after peripheralization to other tissues.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 208436

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  4 in total

Review 1.  Feline leukemia virus: current status of the feline induced immune depression and immunoprevention.

Authors:  R G Olsen; M G Lewis; L J Lafrado; L E Mathes; K Haffer; R Sharpee
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Animal model of human disease: leukemic lymphoma.

Authors:  R G Olsen; L E Mathes; L C Hebebrand; E A Hoover; W S Nichols
Journal:  Am J Pathol       Date:  1980-03       Impact factor: 4.307

Review 3.  Feline leukemia/sarcoma viruses and immunodeficiency.

Authors:  J Rojko; M Essex; Z Trainin
Journal:  Adv Vet Sci Comp Med       Date:  1988

Review 4.  The immunobiology of the feline leukemia virus.

Authors:  J L Rojko; R G Olsen
Journal:  Vet Immunol Immunopathol       Date:  1984-05       Impact factor: 2.046

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.